HS code: 30
Country | |
Direction | |
Country | |
Period | |
Selection products |
Period | Total |
---|---|
2013 | $240 M |
2014 | $225 M |
2015 | $172 M |
2016 | $175 M |
2017 | $195 M |
2018 | $185 M |
2019 | $220 M |
2020 | $200 M |
Total: | $1.61 B |
Period | Weight, tons. |
---|---|
2013 | 13.6 K |
2014 | 12.9 K |
2015 | 14.8 K |
2016 | 12.9 K |
2017 | 10.6 K |
2018 | 9.27 K |
2019 | 12.2 K |
2020 | 12 K |
Total: | 98.3 K |
Group product | 2013 | 2020 | Ch. | ∑ (2013-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | $82.2 K | $7.3 M | 8794% | $12.8 M | 0.8% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $25 M | $55.4 M | 121% | $267 M | 16.6% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | $241 K | $14.4 M | 5875% | $43.9 M | 2.7% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $174 M | $86.7 M | 50% | $988 M | 61.3% |
06 3005: Wadding, gauze, bandages and similar articles | $11.2 M | $7.1 M | 36% | $50.6 M | 3.1% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | $29.4 M | $29.4 M | 0% | $250 M | 15.5% |
Total: | $240 M | $200 M | $1.61 B |
№ | Country | ∑ (2013-2020) | Ratio |
---|---|---|---|
1 | Germany | $225 M | 14% |
2 | Italy | $209 M | 13% |
3 | Belarus | $114 M | 7.1% |
4 | United States | $103 M | 6.4% |
5 | Spain | $99.5 M | 6.2% |
6 | Bosnia and Herzegovina | $94.5 M | 5.9% |
7 | Switzerland | $87.7 M | 5.4% |
8 | Bulgaria | $85.2 M | 5.3% |
9 | Finland | $74.2 M | 4.6% |
10 | Japan | $56.4 M | 3.5% |
11 | Kazakhstan | $45.4 M | 2.8% |
12 | Ukraine | $41.9 M | 2.6% |
13 | United Kingdom | $36.4 M | 2.3% |
14 | France | $34.8 M | 2.2% |
15 | Vietnam | $31.6 M | 2% |
16 | China | $29.7 M | 1.8% |
17 | Morocco | $20.3 M | 1.3% |
18 | Sri Lanka | $17.1 M | 1.1% |
19 | Nicaragua | $15.4 M | 1% |
20 | Lithuania | $14.1 M | 0.9% |
... | ... | ... | ... |
The total for all countries: | $1.61 B | 100% |
№ | Region | ∑ (2013-2020) | Ratio |
---|---|---|---|
1 | Moskva | $77.2 B | 79.7% |
2 | Moskovskaya oblast | $9.82 B | 10.1% |
3 | Nijegorodskaya oblast | $1.94 B | 2% |
4 | Sankt-Peterburg | $1.61 B | 1.7% |
5 | Kalujskaya oblast | $1.06 B | 1.1% |
6 | Kurskaya oblast | $981 M | 1% |
7 | Bashkiriya | $720 M | 0.7% |
8 | Belgorodskaya oblast | $417 M | 0.4% |
9 | Rostovskaya oblast | $398 M | 0.4% |
10 | Vladimirskaya oblast | $328 M | 0.3% |
11 | Smolenskaya oblast | $322 M | 0.3% |
12 | Novosibirskaya oblast | $305 M | 0.3% |
13 | Tatarstan | $171 M | 0.2% |
14 | Tomskaya oblast | $167 M | 0.2% |
15 | Saratovskaya oblast | $139 M | 0.1% |
16 | Kurganskaya oblast | $134 M | 0.1% |
17 | Sverdlovskaya oblast | $132 M | 0.1% |
18 | Altay | $104 M | 0.1% |
19 | Altayskiy kray | $77.9 M | 0.1% |
20 | Penzenskaya oblast | $75.5 M | 0.1% |
... | ... | ... | ... |
By all regions: | $97 B | 100% |